Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2026-02-28 @ 11:15 AM
Study NCT ID:
NCT04190056
Status:
TERMINATED
Last Update Posted:
2023-08-31
First Post:
2019-12-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-04
First Submit QC Date:
None
Study First Post Date:
2019-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-19
Results First Submit QC Date:
None
Results First Post Date:
2023-08-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-09
Last Update Post Date:
2023-08-31
Last Update Post Date Type:
ACTUAL